Literature DB >> 34604197

Retinal Manifestation of an Epstein-Barr Virus-Associated Plasma Cell Neoplasm.

Eda Arslan1, Vita Louisa Sophie Dingerkus1, Florian Moritz Heussen1, Adrian Schmidt2, Kathrin Zaugg3,4, Matthias Dieter Becker1,5, Marc Beer6.   

Abstract

We report a case of an uncommon presentation of Epstein-Barr virus (EBV)-associated plasma cell neoplasm in a patient with a history of prostate cancer and hairy cell leukemia (HCL) in remission after chemotherapy. The diagnosis of an EBV-associated plasma cell neoplasm was challenging as initially the findings were also compatible with a recurrence of HCL. We highlight the value of diagnostic vitrectomy to achieve the diagnosis. Our particular case demonstrates the importance of diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of an unknown cause to confirm the diagnosis.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Diagnostic vitrectomy; Lymphoma; Masquerade syndrome; Uveitis

Year:  2021        PMID: 34604197      PMCID: PMC8443943          DOI: 10.1159/000514842

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  11 in total

1.  Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.

Authors:  Georg Lenz; Alexander Golf; Thomas Rüdiger; Wolfgang Hiddemann; Torsten Haferlach
Journal:  Blood       Date:  2003-11-01       Impact factor: 22.113

Review 2.  Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature.

Authors:  Agata M Bogusz; Adam C Seegmiller; Rolando Garcia; Ping Shang; Raheela Ashfaq; Weina Chen
Journal:  Am J Clin Pathol       Date:  2009-10       Impact factor: 2.493

3.  Unilateral retinal vasculitis associated with hairy cell leukaemia: immunogenetic study.

Authors:  A Di Maria; C Redaelli; A Canevari; G Pagnucco; M Martinetti; P E Bianchi
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

Review 4.  Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Keigo Ikeda; Iwao Sekikawa; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 5.  [Primary Intraocular Lymphoma: Relevance of Diagnostic Vitrectomy].

Authors:  Claudia Helga Le Guin; Klaus Metz; Norbert Bornfeld
Journal:  Klin Monbl Augenheilkd       Date:  2017-11-16       Impact factor: 0.700

6.  Primary ocular Epstein-Barr virus-associated non-Hodgkin's lymphoma in a patient with AIDS: a clinicopathologic report.

Authors:  R A Mittra; J S Pulido; G A Hanson; A Kajdacsy-Balla; C F Brummitt
Journal:  Retina       Date:  1999       Impact factor: 4.256

7.  [Retinopathy as the first symptom of hairy cell leukemia].

Authors:  B Bertram; K Schulte; S Wolf; W M Glöckner; M Reim
Journal:  Klin Monbl Augenheilkd       Date:  1991-10       Impact factor: 0.700

8.  Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine.

Authors:  A Robinson; E Eting; A Zeidman; M Djaldetti; M Mittelman; H Savir
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

9.  Visual disturbance as initial presentation of hairy cell leukemia.

Authors:  Resmi Charalel; Atul Jain; Leelanand Rachakonda; Michael Gaynon
Journal:  Eur J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 2.597

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.